Gruev L, Khinev S, Tikhchev T, Bochev D, Dafinova K, Pelov R, Cherkezov Zh
Khirurgiia (Sofiia). 1993;46(5):53-5.
The anesthesiologic risk in ischemic heart disease (IHD) patients undergoing noncardiac surgery is determined by the duration of myocardial infarction sustained in the past, and the degree (severity) of stenocardia manifestations. Such risk is estimated as minimal within six months after myocardial infarction in the presence of stenocardia stabilization. In this contingent of patients the anti-ischemic therapy is proceeded with in both pre- and postoperative period. The role of beta-adrenergic blocking agents (propranolol, acebutolol, esmolol, sotalol) and calcium antagonists (nifedipine, diltiazem) in the prophylaxis against intraoperative myocardial ischemia, rhythm disorders and pathologic arterial pressure rise is definitely proved.
接受非心脏手术的缺血性心脏病（IHD）患者的麻醉风险取决于过去心肌梗死的持续时间以及心绞痛表现的程度（严重程度）。在心绞痛稳定的情况下，心肌梗死后六个月内这种风险被估计为最低。在这类患者中，围手术期均需进行抗缺血治疗。β-肾上腺素能阻滞剂（普萘洛尔、醋丁洛尔、艾司洛尔、索他洛尔）和钙拮抗剂（硝苯地平、地尔硫䓬）在预防术中心肌缺血、心律失常和病理性血压升高中的作用已得到明确证实。
